MARKET

MYGN

MYGN

Myriad Genetics
NASDAQ
5.99
-0.01
-0.17%
After Hours: 5.99 0 0.00% 17:54 07/02 EDT
OPEN
6.05
PREV CLOSE
6.00
HIGH
6.12
LOW
5.92
VOLUME
1.32M
TURNOVER
--
52 WEEK HIGH
8.59
52 WEEK LOW
3.530
MARKET CAP
565.74M
P/E (TTM)
-1.3880
1D
5D
1M
3M
1Y
5Y
1D
Myriad says meta-analysis supports prognostic performance of Prolaris biopsy test in localized prostate cancer
PUBT · 2d ago
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
Barchart · 2d ago
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
Barchart · 4d ago
Sera Prognostics names former Myriad Genetics CEO Mark Capone to board
PUBT · 4d ago
Weekly Report: what happened at MYGN last week (0622-0626)?
Weekly Report · 5d ago
Why Is Myriad Genetics (MYGN) Stock Rocketing Higher Today
Barchart · 06/24 10:40
Illumina Appoints Daniel Skovronsky To Its Board
NASDAQ · 06/24 08:49
Myriad Genetics Announces Resignation of Board Member Skovronsky
TipRanks · 06/23 13:19
More
About MYGN
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.

Webull offers Myriad Genetics Inc stock information, including NASDAQ: MYGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MYGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MYGN stock methods without spending real money on the virtual paper trading platform.